GM23345
LCL from B-Lymphocyte
Description:
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20
MELANOCORTIN 4 RECEPTOR; MC4R
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
ISCN
|
46,XX.arr(1-22,X)x2
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
MC4R |
Chromosomal Location |
18q22 |
Allelic Variant 1 |
; OBESITY |
Identified Mutation |
806T>A |
Remarks |
Clinically affected; night terrors at 18 months old; food obsession and weight gain at 3 years old; food seeking and food hiding behaviors at 5 years old; hyperphagia; behavior problems including rage episodes and impulsivity; anxious; attention deficient hyperactivity disorder; hypercholesterolemia (levels of 225-238 since age 2 years old); elevated cholesterol, triglyceride, and LDL cholesterol; obesity; asthma; nearsighted; uses glasses; astigmatism; short fourth and fifth metacarpals; fifth finger clinodactyly; tapering fingers; normal IQ; tall; heterozygous for a T>A transversion at nucleotide 806 in the MC4R gene (c.806T>A) resulting in amino acid change p.Ile269Asn; Prader-Willi Syndrome-like symptoms, though there is insufficient clinical evidence for PWS diagnosis; medications include albuterol; treatments include: dietary management. |
Tang Z, Berlin DS, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP, A dynamic database of microarray-characterized cell lines with various cytogenetic and genomic backgrounds G3 (Bethesda, Md)3:1143-9 2013 |
PubMed ID: 23665875 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|